| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,¶
*
Research Center and
Nephrology Service, Notre-Dame Hospital, Center hospitalier universitaire de l’Université de Montréal, University of Montreal, Montreal, Canada;
Montreal General Hospital, Montreal, Canada;
Institute of Molecular Virology, St. Louis University Medical Center, St. Louis, MO 63110; and
¶ Department of Surgery, McGill University, Montreal, Canada
The mechanism underlying apoptosis induced by proteasome inhibition in leukemic Jurkat and Namalwa cells was investigated in this study. The proteasome inhibitor lactacystin differentially regulated the protein levels of proapoptotic Bcl-2 family members and Bik was accumulated at the mitochondria. Bik overexpression sufficed to induce apoptosis in these cells. Detailed examination along the respiration chain showed that lactacystin compromised a step after complex III, and exogenous cytochrome c could overcome this compromise. Probably as a result, the succinate-stimulated generation of mitochondrial membrane potential was significantly diminished. Bcl-xL interacted with Bik in the cells, and Bcl-xL overexpression prevented cytochrome c leakage out of the mitochondria, corrected the mitochondrial membrane potential defect, and protected the cells from apoptosis. These results show that proteasomes can modulate apoptosis of lymphocytes by affecting the half-life of Bcl-2 family members, Bik being one of them.
This article has been cited by other articles:
|
|
 |
|
  G. W. Dorn II Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling Cardiovasc Res, February 15, 2009; 81(3): 465 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W.G. Tait, E. de Vries, C. Maas, A. M. Keller, C. S. D'Santos, and J. Borst Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment J. Cell Biol., December 31, 2007; 179(7): 1453 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Subramanian, S. Vijayalingam, E. Lomonosova, L.-j. Zhao, and G. Chinnadurai Evidence for Involvement of BH3-Only Proapoptotic Members in Adenovirus-Induced Apoptosis J. Virol., October 1, 2007; 81(19): 10486 - 10495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. O'Connor Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways Hematology, January 1, 2007; 2007(1): 270 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ruiz, Y. Krupnik, M. Keating, J. Chandra, M. Palladino, and D. McConkey The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. Mol. Cancer Ther., July 1, 2006; 5(7): 1836 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. O'Connor, E. A. Smith, L. E. Toner, J. Teruya-Feldstein, S. Frankel, M. Rolfe, X. Wei, S. Liu, G. Marcucci, K. K. Chan, et al. The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide. Clin. Cancer Res., May 1, 2006; 12(9): 2902 - 2911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kwon, K. Mochida, Y.-L. Wang, S. Sekiguchi, T. Sankai, S. Aoki, A. Ogura, Y. Yoshikawa, and K. Wada Ubiquitin C-Terminal Hydrolase L-1 Is Essential for the Early Apoptotic Wave of Germinal Cells and for Sperm Quality Control During Spermatogenesis Biol Reprod, July 1, 2005; 73(1): 29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gelinas and E. White BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis Genes & Dev., June 1, 2005; 19(11): 1263 - 1268. [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Magal, A. Jackman, S. Ish-Shalom, L. E. Botzer, P. Gonen, R. Schlegel, and L. Sherman Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16 J. Gen. Virol., March 1, 2005; 86(3): 611 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nikrad, T. Johnson, H. Puthalalath, L. Coultas, J. Adams, and A. S. Kraft The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim Mol. Cancer Ther., March 1, 2005; 4(3): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. O'Connor, J. Wright, C. Moskowitz, J. Muzzy, B. MacGregor-Cortelli, M. Stubblefield, D. Straus, C. Portlock, P. Hamlin, E. Choi, et al. Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma J. Clin. Oncol., February 1, 2005; 23(4): 676 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Denlinger, B. K. Rundall, and D. R. Jones Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kwon, Y.-L. Wang, R. Setsuie, S. Sekiguchi, Y. Sato, M. Sakurai, M. Noda, S. Aoki, Y. Yoshikawa, and K. Wada Two Closely Related Ubiquitin C-Terminal Hydrolase Isozymes Function as Reciprocal Modulators of Germ Cell Apoptosis in Cryptorchid Testis Am. J. Pathol., October 1, 2004; 165(4): 1367 - 1374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Chen and J.-K. Lin Induction of G1 Arrest and Apoptosis in Human Jurkat T Cells by Pentagalloylglucose through Inhibiting Proteasome Activity and Elevating p27Kip1, p21Cip1/WAF1, and Bax Proteins J. Biol. Chem., April 2, 2004; 279(14): 13496 - 13505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Fisher, T. P. Miller, and O. A. O'Connor Diffuse Aggressive Lymphoma Hematology, January 1, 2004; 2004(1): 221 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. YANG and X. YU Regulation of apoptosis: the ubiquitous way FASEB J, May 1, 2003; 17(8): 790 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Kim, H. R. Bae, B. S. Park, J. M. Lee, H. B. Ahn, J. H. Rho, K. W. Yoo, W. C. Park, S. H. Rho, H. S. Yoon, et al. Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chandrashekhar and J. Narula Death Hath a Thousand Doors To Let Out Life... Circ. Res., April 18, 2003; 92(7): 710 - 714. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tonomura, K. McLaughlin, L. Grimm, R. A. Goldsby, and B. A. Osborne Glucocorticoid-Induced Apoptosis of Thymocytes: Requirement of Proteasome-Dependent Mitochondrial Activity J. Immunol., March 1, 2003; 170(5): 2469 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ravandi, M. Talpaz, and Z. Estrov Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies Clin. Cancer Res., February 1, 2003; 9(2): 535 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Panaretakis, K. Pokrovskaja, M. C. Shoshan, and D. Grander Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to Doxorubicin J. Biol. Chem., November 8, 2002; 277(46): 44317 - 44326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Grolleau, J. Bowman, B. Pradet-Balade, E. Puravs, S. Hanash, J. A. Garcia-Sanz, and L. Beretta Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and Proteomics J. Biol. Chem., June 14, 2002; 277(25): 22175 - 22184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pati, C. B. Pelser, J. Dufraine, J. L. Bryant, M. S. Reitz Jr, and F. F. Weichold Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma Blood, May 15, 2002; 99(10): 3771 - 3779. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
